Navigation Links
Rising Incidence of Stroke Drives the Global Intracranial Stents Market, According to New Report by Global Industry Analysts, Inc.

San Jose, California (PRWEB) August 29, 2013

Follow us on LinkedIn – Stroke is one of the leading causes of morbidity and mortality in the world. Aging population constitutes a major growth engine for the global intracranial stents market, given that people above the age of 40 years are at a higher risk of developing cerebrovascular diseases. The fast aging societies in advanced economies of North America, Western Europe and Japan coupled with the huge aging demography in highly populous developing economies such as China and India, are expected to result in a considerable increase in health conditions warranting a rise in demand for intracranial stenting procedures. Additionally, changing lifestyles, increasing stress levels, hypertension, rising obesity rates, increasing blood cholesterol and blood pressure levels, smoking and hyperlipidemia, among others are some of the major factors that have increased the incidence rates of stroke. The rising number of cases of restenosis, indicated by the recurrence of stenosis and subsequent constriction in blood flow in previously treated arteries, is fuelling the requirement for intracranial stenting procedures.

Conventional therapy involves the prescription of aspirin, Warfarin and other blood thinning agents for restoring normal blood flow in patients with narrowed arteries. Intracranial Stents, inspired by the coronary and cardiovascular stent systems, have revolutionized treatment of arterial blockages and clot retrieval in patients suffering with cerebral aneurysms, severe intracranial atherosclerotic disease (ICAD), intracranial stenosis, acute ischemic stroke and other diseases of the brain. These stenting systems have been successfully used in revascularization of the brain tissue by restoring normal blood flow to the brain.

With the US and European healthcare industry reaching saturation, emerging markets are being recognized as the growth frontiers of the future, especially in the medical devices market. An affluent consumer base, increasing access to healthcare services and facilities, favorable regulatory scenario and unmet medical needs are encouraging multinational companies and upcoming local players to set up production facilities and sales offices in these markets. MNCs are focusing on improving product offerings in the premium category. Developments in mid-tier products are anticipated to emerge as the new growth wave in the coming years.

The high cost of medical treatment procedures in developed economies has fuelled the popularity of medical tourism. A large number of people seeking medical treatment, including neurovascular surgeries are travelling to developing countries where the cost of medical procedures and therapies are relatively cheaper and more affordable. Besides the lower cost of treatment, several developing countries offer quality healthcare on par with the best in class medical services available in advanced economies. The trend of medical tourism for neurovascular surgeries is therefore expected to drive demand for intracranial stents in the coming years.

As stated by the new market research report on Intracranial Stents, the United States represents the largest market worldwide, followed by Europe. Asia-Pacific, Middle East and Latin America are forecast to spearhead future growth led by rising incidence of stroke, increasing healthcare spending and improving quality of healthcare services.

Key players covered in the report include Admedes Schuessler GmbH, BALT Extrusion, Cardiatis SA, Codman & Shurtleff Inc, Covidien PLC, ITGI Medical Ltd, Medtronic Inc, MicroPort Scientific Corporation, OBEX Medical, Penumbra Inc and Stryker Corporation.

The research report titled "Intracranial Stents: A Global Strategic Business Report" announced by Global Industry Analysts Inc., provides a comprehensive review of the market, industry overview, trends, growth drivers, product launches, and corporate activity. The report provides market estimates and projections in US$ for geographic markets including the United States, Europe and Rest of World.

For more details about this comprehensive market research report, please visit –

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site:

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Rising Interest of Big Pharma Creates Immense Growth Potential for Contract Manufacturing Organisations, Says Frost & Sullivan
2. Trending HealthEconomics.Com Pharma Pricing, Reimbursement, and Health Policy Stories Feature Rising Trend in Pharma Price Cuts to Secure Reimbursement
3. Healthcare Sales Jobs Rising Despite Challenges Facing the Industry
4. Blood Glucose Testing and Diabetes Management - Dramatic Increase in the Incidence of Diabetes
5. Black Women Have Higher Incidence of Multiple Sclerosis than White Women
6. Results of new exploratory analyses assessing the incidence of hypoglycemia with linagliptin in adults with type 2 diabetes announced
7. Powerful AAC Device With Intel® i7 Processor Enables Natural Communication for Stroke, ALS and Autism Patients
8. Providence Health & Services Inks Deal with Remedy Informatics for Orthopedic and Stroke Registries
9. Latest Advances in Treatment for Alzheimers, Traumatic Brain Injury and Stroke to Be Presented at Symposium
10. St. Josephs Hospital is the First in Florida to Offer Non-invasive Test to Predict Stroke Risk
11. National Stroke Association Teams With Clinical Trial Matching Service CureLauncher
Post Your Comments:
(Date:11/24/2015)... , Nov. 24, 2015  Twist Bioscience, a ... Emily Leproust, Ph.D., Twist Bioscience chief executive officer, ... Conference on December 1, 2015 at 3:10 p.m. ... York City. --> ... . Twist Bioscience is on Twitter. Sign up ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... OrthoAccel® Technologies, Inc., on being named to Deloitte's 2015 Technology Fast 500 list ... facility, OrthoAccel manufactures AcceleDent®, a FDA-cleared, Class II medical device that speeds up ...
(Date:11/24/2015)... CHARLOTTESVILLE, Va. , Nov. 24, 2015 /PRNewswire/ ... company focused on discovering drugs for metabolic disorders, ... Watkins to its Board of Directors (BOD). ... executive officer of Human Genome Sciences (HGS), and ... Industry Organization. Jim Powers , Chairman ...
(Date:11/24/2015)... ... November 24, 2015 , ... Whitehouse Laboratories is pleased ... The new stand-alone facility will be strictly dedicated to basic USP 61, USP 62 ... clients the chance to have complete chemistry and micro testing performed by one supplier. ...
Breaking Biology Technology:
(Date:11/12/2015)... golden retriever that stayed healthy despite having the gene ... new lead for treating this muscle-wasting disorder, report scientists ... and Harvard and the University of São Paolo in ... pinpoints a protective gene that boosts muscle regeneration, ... Children,s lab of Lou Kunkel , PhD, is ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
Breaking Biology News(10 mins):